Efficacy and safety of an innovative short-course regimen containing clofazimine for treatment of drug-susceptible tuberculosis: a clinical trial.
Zheng X, Gui X, Yao L, Ma J, He Y, Lou H, Gu J, Ying R, Chen L, Sun Q, Liu Y, Ho CM, Lee BY, Clemens DL, Horwitz MA, Ding X, Hao X, Yang H, Sha W.
Zheng X, et al. Among authors: lee by.
Emerg Microbes Infect. 2023 Dec;12(1):2187247. doi: 10.1080/22221751.2023.2187247.
Emerg Microbes Infect. 2023.
PMID: 36872899
Free PMC article.
Clinical Trial.